Your selection

Research / 06.02.2026
Professorship awarded to Mina Gouti

Mina Gouti © Pablo Castagnola / MDC
Mina Gouti © Pablo Castagnola / MDC

Mina Gouti has been awarded a professorship at Charité – Universitätsmedizin Berlin. The appointment will strengthen her pioneering organoid research at the Max Delbrück Center and deepen collaboration with clinicians to advance personalized medicine.

Dr. Mina Gouti, Group Leader of the Stem Cell Modeling of Development and Disease lab at the Max Delbrück Center, has been appointed W3 Professor of Complex Organoid Models for Personalized Medicine in the Medical Faculty, Charité – Universitätsmedizin Berlin. The permanent position recognizes her achievements in developing advanced organoid systems to understand how specific types of spinal cord neurons and skeletal muscle cells grow in space and time during development.

“This professorship will enable my team to fully leverage Berlin’s exceptional biomedical ecosystem and to work closely with clinicians at Charité to create complex organoids for personalized medicine,” Gouti says. This close interaction is essential for translating patient-derived organoid models into clinically relevant insights.”

The Gouti lab has developed three-dimensional neuromuscular organoids from human pluripotent stem cells that replicate key features of spinal cord neurons and skeletal muscle – providing powerful platforms for studying neuromuscular diseases such as spinal muscular atrophy and amyotrophic lateral sclerosis, and for drug screening. Such organoids can also be grown from cells derived from individual patients to model their specific disease.

The position reflects a shared vision between the Max Delbrück Center and Charité to accelerate translational research through fostering closer collaboration between clinicians researchers. “We now have the long-term perspective required to develop complex, functional organoids as predictive platforms for personalized medicine and early disease interception,” says Gouti. “We hope our research will lead to better health outcomes not only for people with neuromuscular diseases, but also those at high risk of developing them.”

Text: Gunjan Sinha

Further information

Overview News

News Buch Berlin

Eckert & Ziegler: Strong FY 2025 with Positive Outlook

Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) set a new record in fiscal year 2025 with sales of €312.0 million. Compared to the previous year, sales rose by approximately €16 million (+5%).

more ...

Launch of the Einstein Center for Early Disease Interception

At the Einstein Center for Early Disease Interception, researchers from twelve Berlin institutions will be pooling their expertise to explore new approaches to prevention, long before symptoms appear,...

more ...

Strengthen international cooperation in clinical trials

As part of the Australian Clinical Trials Initiative, ACTI, Australian companies and representatives of the Australien Government’s Trade and Invest Commission, Austrade, visited the Berlin-Buch Scien...

more ...

Events Buch Berlin

03.04.2026, 17:00
Passionsmusik mit Kantaten von Bach

mit der St.-Annen-Kantorei und dem Neuen Barockorchester Berlin

more ...

04.04.2026, 16:00
Traditionelles Osterfeuer auf dem Stadtgut Berlin-Buch

in familiärer Atmosphäre - für das leibliche Wohl ist gesorgt

more ...

05.04.2026, 11:00
Tierische Ostern im Schildi-Park

Mit Esel, Alpaka, Ziegen, Eierparcours, Eiertrudeln, Osterhasen, Stockbrot, Ständen uvm.

more ...

This website is supported by: